749 related articles for article (PubMed ID: 19854630)
1. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
2. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
[TBL] [Abstract][Full Text] [Related]
3. Clinical importance of cystic fibrosis-related diabetes.
Brennan AL; Geddes DM; Gyi KM; Baker EH
J Cyst Fibros; 2004 Dec; 3(4):209-22. PubMed ID: 15698938
[TBL] [Abstract][Full Text] [Related]
4. Glucose intolerance in cystic fibrosis patients.
Lanng S
Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
[TBL] [Abstract][Full Text] [Related]
5. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.
Sterescu AE; Rhodes B; Jackson R; Dupuis A; Hanna A; Wilson DC; Tullis E; Pencharz PB
J Pediatr; 2010 Apr; 156(4):613-7. PubMed ID: 19962154
[TBL] [Abstract][Full Text] [Related]
6. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
[TBL] [Abstract][Full Text] [Related]
7. [Continuous glucose monitoring system in the screening of glucose disorders in cystic fibrosis].
Martín-Frías M; Lamas Ferreiro A; Colino Alcol E; Alvarez Gómez MA; Yelmo Valverde R; Barrio Castellanos R
An Pediatr (Barc); 2009 Feb; 70(2):120-5. PubMed ID: 19217566
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
[TBL] [Abstract][Full Text] [Related]
9. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
Leclercq A; Gauthier B; Rosner V; Weiss L; Moreau F; Constantinescu AA; Kessler R; Kessler L
J Cyst Fibros; 2014 Jul; 13(4):478-84. PubMed ID: 24359972
[TBL] [Abstract][Full Text] [Related]
10. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
Lek N; Acerini CL
Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of ADA and WHO diagnostic criteria for diabetes diagnosis and other categories of glucose intolerance ].
Herdzik E; Safranow K; Ciechanowski K; Byra E; Gołdyn U
Pol Merkur Lekarski; 2002 Oct; 13(76):316-20. PubMed ID: 12557440
[TBL] [Abstract][Full Text] [Related]
13. Demographics of glucose metabolism in cystic fibrosis.
van den Berg JM; Kouwenberg JM; Heijerman HG
J Cyst Fibros; 2009 Jul; 8(4):276-9. PubMed ID: 19467621
[TBL] [Abstract][Full Text] [Related]
14. Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study.
Hammana I; Coderre L; Potvin S; Costa M; Berthiaume Y; Lavoie A; Chiasson JL; Levy E; Rabasa-Lhoret R
J Cyst Fibros; 2009 Mar; 8(2):128-34. PubMed ID: 19083274
[TBL] [Abstract][Full Text] [Related]
15. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
[TBL] [Abstract][Full Text] [Related]
16. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status.
Costa M; Potvin S; Hammana I; Malet A; Berthiaume Y; Jeanneret A; Lavoie A; Lévesque R; Perrier J; Poisson D; Karelis AD; Chiasson JL; Rabasa-Lhoret R
J Cyst Fibros; 2007 Nov; 6(6):376-83. PubMed ID: 17409029
[TBL] [Abstract][Full Text] [Related]
17. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
Adam JM; Tarigan NP
Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
[TBL] [Abstract][Full Text] [Related]
18. Improving screening for cystic fibrosis-related diabetes at a pediatric cystic fibrosis program.
Kern AS; Prestridge AL
Pediatrics; 2013 Aug; 132(2):e512-8. PubMed ID: 23821699
[TBL] [Abstract][Full Text] [Related]
19. [Research of factors for glucose intolerance in mucoviscidosis].
Robert JJ; Grasset E; de Montalembert M; Chevenne D; Deschamps I; Boitard C; Lenoir G
Arch Fr Pediatr; 1992 Jan; 49(1):17-22. PubMed ID: 1550446
[TBL] [Abstract][Full Text] [Related]
20. Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention.
White H; Pollard K; Etherington C; Clifton I; Morton AM; Owen D; Conway SP; Peckham DG
J Cyst Fibros; 2009 May; 8(3):179-85. PubMed ID: 19179122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
